Robert W. Hesslein insider trades

Open-market stock purchases and sales by Robert W. Hesslein, EVP, CLO and Secretary at Alnylam Pharmaceuticals, Inc, from SEC Form 4 filings since Jul 8, 2014.

Recent trades

No open-market trades in the last 12 months.

Companies traded

ALNY Alnylam Pharmaceuticals, Inc: other filings, last Mar 3, 2025
VYGR Voyager Therapeutics, Inc: 13 sales, last Mar 20, 2023
FMI Foundation Medicine, Inc: 26 sales, last Jul 31, 2018

Get free alerts when Robert W. Hesslein files a new trade →